VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a significant increase in the powerful capabilities of its QIAcuity Digital PCR (dPCR) system ...
Without doubt, PCR still serves as a workhorse technology for biotechnology studies. But it has also grown in value as an important exploratory tool for new directions and applications in life science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results